NCT05413330View on ClinicalTrials.gov

Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

September 12, 2020

Primary Completion Date

January 5, 2022

Study Completion Date

March 29, 2022

Conditions
Diabete Type 2CataractTriamcinolone AcetonideIntravitreal Injection
Interventions
DRUG

Triamcinolone Acetonide

Intravitreal injection of 4 mg/0.1 mL preservative-free triamcinolone acetonide at the end of phacoemulsification surgery will be injected at 3.5 mm inferolateral and posterior to the limbus.

Trial Locations (1)

00000

Damascus University, Damascus

All Listed Sponsors
lead

Damascus University

OTHER

NCT05413330 - Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes. | Biotech Hunter | Biotech Hunter